Structural identification and cardiovascular activities of oxidized phospholipids

Circulation Research

Volumn 111, Issue 7, 2012, Pages 930-946

  Salomon, Robert G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

atherosclerosis; cardiovascular disease; lipids; oxidative stress; thrombosis

Indexed keywords

1 PALMITYL 2 (5 OXOVALERYL) SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITYL 2 (9 OXONONANOYL) SN GLYCERO 3 PHOSPHOCHOLINE; APOPTOSIS INDUCING FACTOR; CD36 ANTIGEN; CYCLOPENTENONE DERIVATIVE; ENDOPEROXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; GAMMA HYDROXYALKENAL PHOSPHOLIPID; GAMMA INTERFERON; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 8; ISOPROSTANE DERIVATIVE; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPID DERIVATIVE; PROSTAGLANDIN E2; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 2;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR SYSTEM; CATALYSIS; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CYCLIZATION; CYTOTOXICITY; DERIVATIZATION; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME ISOLATION; ENZYME METABOLISM; ENZYME STRUCTURE; ENZYME SYNTHESIS; FRAGMENTATION REACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; ISOMER; LIGAND BINDING; LIPID OXIDATION; LIPID RAFT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MITOCHONDRION SWELLING; MONOCYTE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATION-REDUCTION; PHOSPHOLIPIDS; THROMBOSIS;

EID: 84866536186     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.275388     Document Type: Review

References (74)

1. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA. Structural identification by mass spec-trometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997;272:13597-13607.
2. Berliner JA, Gharavi NM. Endothelial cell regulation by phospholipid oxidation products. Free Radic Biol Med. 2008;45:119-123.
3. Berliner JA, Leitinger N, Tsimikas S. The role of oxidized phospholipids in atherosclerosis. J Lipid Res. 2009;50:S207-S212.
4. Bochkov VN. Inflammatory profile of oxidized phospholipids. Thromb Haemost. 2007;97:348-354.
5. Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, Stockl J. Generation and biological activities of oxidized phospholipids. Antioxidant Redox Signal. 2010;12:1009-1059.
6. Gargalovic PS, Imura M, Zhang B, Gharavi NM, Clark MJ, Pagnon J, Yang WP, He A, Truong A, Patel S, Nelson SF, Horvath S, Berliner JA, Kirchgessner TG, Lusis AJ. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci U S A. 2006;103:12741-12746.
7. Zimman A, Chen SS, Komisopoulou E, Titz B, Martinez-Pinna R, Kafi A, Berliner JA, Graeber TG. Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis. J Proteome Res. 2010;9:2812-2824.
8. Tseng W, Lu J, Bishop GA, Watson AD, Sage AP, Demer L, Tintut Y. Regulation of interleukin-6 expression in osteoblasts by oxidized phos-pholipids. J Lipid Res. 2010;51:1010-1016.
9. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
10. Tokumura A, Asai T, Takauchi K, Kamiyasu K, Ogawa T, Tsukatani H. Novel phospholipids with aliphatic dicarboxylic acid residues in a lipid extract from bovine brain. Biochem Biophys Res Commun. 1988;155:863-869.
11. Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM. Oxidatively modified LDL contains phos-pholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest. 1995;96:2322-2330.
12. Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, Berliner JA, Vora DK. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci U S A. 1999;96:12010-12015.
13. Chatterjee S, Berliner JA, Subbanagounder GG, Bhunia AK, Koh S. Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation. Glycoconjugate J. 2004;20:331-338.
14. Cole AL, Subbanagounder G, Mukhopadhyay S, Berliner JA, Vora DK. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a camp-dependent r-ras/pi3-kinase pathway. Arterioscler Thromb Vasc Biol. 2003;23:1384-1390.
15. Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, Nagy L. Role for per-oxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res. 2000;87:516-521.
16. Bochkov VN, Kadl A, Huber J, Gruber F, Binder BR, Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature. 2002;419:77-81.
17. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307-2315.
18. Chen R, Yang L, McIntyre TM. Cytotoxic phospholipid oxidation products: cell death from mitochondrial damage and the intrinsic caspase cascade. J Biol Chem. 2007;282:24842-24850.
19. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor cd36 and is enriched in atherosclerotic lesions. J Biol Chem. 2002;277:38517-38523.
20. Chen R, Brady E, McIntyre TM. Human TMEM30A promotes uptake of antitumor and bioactive choline phospholipids into mammalian cells. J Immunol. 2011;186:3215-3225.
21. Watson AD, Subbanagounder G, Welsbie DS, Faull KF, Navab M, Jung ME, Fogelman AM, Berliner JA. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein. J Biol Chem. 1999;274:24787-24798.
22. Jung ME, Berliner JA, Angst D, Yue D, Koroniak L, Watson AD, Li R. Total synthesis of the epoxy isoprostane phospholipids peipc and pecpc. Organic Lett. 2005;7:3933-3935.
23. Jung ME, Berliner JA, Koroniak L, Gugiu BG, Watson AD. Improved synthesis of the epoxy isoprostane phospholipid peipc and its reactivity with amines. Organic Lett. 2008;10:4207-4209.
24. Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, Mouillesseaux KP, Cole AL, Reddy ST, Berliner JA. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-SRC/signal transducers and activators of transcription (stat)3 pathway. J Biol Chem. 2004;279:30175-30181.
25. Li R, Mouillesseaux KP, Montoya D, Cruz D, Gharavi N, Dun M, Koroniak L, Berliner JA. Identification of prostaglandin e2 receptor subtype 2 as a receptor activated by oxpapc. Circ Res. 2006;98:642-650.
26. Subbanagounder G, Wong JW, Lee H, Faull KF, Miller E, Witztum JL, Berliner JA. Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis: formation of these oxidized phospholipids in response to interleukin-1beta. J Biol Chem. 2002;277:7271-7281.
27. Walton KA, Hsieh X, Gharavi N, Wang S, Wang G, Yeh M, Cole AL, Berliner JA. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3- phosphorylcholine-mediated synthesis of interleukin-8: a role for toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J Biol Chem. 2003;278:29661-29666.
28. Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, Wei L, Pfeffer LM, Berliner JA. Role of the jak/stat pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem. 2007;282:31460-31468.
29. Zimman A, Mouillesseaux KP, Le T, Gharavi NM, Ryvkin A, Graeber TG, Chen TT, Watson AD, Berliner JA. Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2007;27:332-338.
30. Gharavi NM, Baker NA, Mouillesseaux KP, Yeung W, Honda HM, Hsieh X, Yeh M, Smart EJ, Berliner JA. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospho-lipids. Circ Res. 2006;98:768-776.
31. Yeh M, Cole AL, Choi J, et al. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ Res. 2004;95:780-788.
32. Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark MJ, Szeto WL, Watson AD, Lusis AJ, Berliner JA. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proin-flammatory to anti-inflammatory. Arterioscler Thromb Vasc Biol. 2007; 27:1346-1353.
33. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of camp-responsive element-binding protein. J Biol Chem. 2003;278:51006-51014.
34. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol. 2000;20:2248-2254.
35. Birukov KG, Bochkov VN, Birukova AA, Kawkitinarong K, Rios A, Leitner A, Verin AD, Bokoch GM, Leitinger N, Garcia JG. Epoxycyclopentenone-containing oxidized phospholipids restore endo-thelial barrier function via CDC42 and Rac. Circ Res. 2004;95:892-901.
36. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, Modlin RL. Host-derived oxidized phos-pholipids and HDL regulate innate immunity in human leprosy. J Clin Invest. 2008;118:2917-2928.
37. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, Hazen SL. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem. 2002;277:38503-38516.
38. Smiley PL, Stremler KE, Prescott SM, Zimmerman GA, McIntyre TM. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J Biol Chem. 1991; 266:11104-11110.
39. Subbanagounder G, Deng Y, Borromeo C, Dooley AN, Berliner JA, Salomon RG. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vasc Pharmacol. 2002;38:201-209.
40. Hoff HF, O'Neil J, Wu Z, Hoppe G, Salomon RL. Phospholipid hydroxy-alkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2003; 23:275-282.
41. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286:2136-2142.
42. Sayre LM, Sha W, Xu G, Kaur K, Nadkarni D, Subbanagounder G, Salomon RG. Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem Res Toxicol. 1996;9:1194-1201.
43. Salomon RG, Hong L, Hollyfield JG. Discovery of carboxyethylpyrroles (CEPS): critical insights into AMD, autism, cancer, and wound healing from basic research on the chemistry of oxidized phospholipids. Chem Res Toxicol. 2011;24:1803-1816.
44. Kaur K, Salomon RG, O'Neil J, Hoff HF. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem Res Toxicol. 1997;10:1387-1396.
45. Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, Crabb JW, Salomon RG. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem. 2003;278:42027-42035.
46. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008;14:194-198.
47. Ebrahem Q, Renganathan K, Sears J, Vasanji A, Gu X, Lu L, Salomon RG, Crabb JW, Anand-Apte B. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration. Proc Natl Acad Sci U S A. 2006;103:13480-13484.
48. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, Podrez EA, Salomon RG, Byzova TV. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 2010;467:972-976.
49. Hoppe G, Subbanagounder G, O'Neil J, Salomon RG, Hoff HF. Macrophage recognition of LDL modified by levuglandin e2, an oxidation product of arachidonic acid. Biochim Biophys Acta. 1997;1344:1-5.
50. Sun M, Deng Y, Batyreva E, Sha W, Salomon RG. Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine. J Organic Chem. 2002;67:3575-3584.
51. Sun M, Finnemann SC, Febbraio M, Shan L, Annangudi SP, Podrez EA, Hoppe G, Darrow R, Organisciak DT, Salomon RG, Silverstein RL, Hazen SL. Light-induced oxidation of photoreceptor outer segment phos-pholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions. J Biol Chem. 2006;281:4222-4230.
52. Colles SM, Irwin KC, Chisolm GM. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. J Lipid Res. 1996;37:2018-2028.
53. Hoppe G, Marmorstein AD, Pennock EA, Hoff HF. Oxidized low density lipoprotein-induced inhibition of processing of photoreceptor outer segments by RPE. Invest Ophthalmol Vis Sci. 2001;42:2714-2720.
54. Hoppe G, O'Neil J, Hoff HF, Sears J. Accumulation of oxidized lipid-protein complexes alters phagosome maturation in retinal pigment epithelium. Cell Mol Life Sci. 2004;61:1664-1674.
55. Hoppe G, O'Neil J, Hoff HF, Sears J. Products of lipid peroxidation induce missorting of the principal lysosomal protease in retinal pigment epithelium. Biochim Biophys Acta. 2004;1689:33-41.
56. Alvarez-Dominguez C, Stahl PD. Interferon-gamma selectively induces rab5a synthesis and processing in mononuclear cells. J Biol Chem. 1998; 273:33901-33904.
57. Connelly MA, Williams DL. Scavenger receptor Bi: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol. 2004;15:287-295.
58. Jessup W, Gelissen IC, Gaus K, Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor Bi and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol. 2006;17:247-257.
59. Rigotti A, Miettinen HE, Krieger M. The role of the high-density lipo-protein receptor SR-Bi in the lipid metabolism of endocrine and other tissues. Endocr Rev. 2003;24:357-387.
60. Ashraf MZ, Kar NS, Chen X, Choi J, Salomon RG, Febbraio M, Podrez EA. Specific oxidized phospholipids inhibit scavenger receptor Bi-mediated selective uptake of cholesteryl esters. J Biol Chem. 2008; 283:10408-10414.
61. Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL. Platelet cd36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med. 2007;13:1086-1095.
62. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004;95:764-772.
63. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Ann Rev Biochem. 2000;69:419-445.
64. Chen R, Chen X, Salomon RG, McIntyre TM. Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor. Arterioscler Thromb Vasc Biol. 2009;29:363-371.
65. Gugiu BG, Salomon RG. Total syntheses of bioactive oxidized etha-nolamine phospholipids. Organic Lett. 2003;5:2797-2799.
66. Gugiu BG, Mesaros CA, Sun M, Gu X, Crabb JW, Salomon RG. Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsaturated phosphatidylethanolamines. Chem Res Toxicol. 2006;19:262-271.
67. Walton KA, Gugiu BG, Thomas M, Basseri RJ, Eliav DR, Salomon RG, Berliner JA. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J Lipid Res. 2006;47:1967-1974.
68. Li XM, Salomon RG, Qin J, Hazen SL. Conformation of an endogenous ligand in a membrane bilayer for the macrophage scavenger receptor CD36. Biochemistry. 2007;46:5009-5017.
69. Greenberg ME, Li XM, Gugiu BG, Gu X, Qin J, Salomon RG, Hazen SL. The lipid whisker model of the structure of oxidized cell membranes. J Biol Chem. 2008;283:2385-2396.
70. Khandelia H, Mouritsen OG. Lipid gymnastics: evidence of complete acyl chain reversal in oxidized phospholipids from molecular simulations. Biophys J. 2009;96:2734-2743.
71. Epand RF, Mishra VK, Palgunachari MN, Anantharamaiah GM, Epand RM. Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids. Biochim Biophys Acta. 2009;1788:1967-1975.
72. Boullier A, Friedman P, Harkewicz R, Hartvigsen K, Green SR, Almazan F, Dennis EA, Steinberg D, Witztum JL, Quehenberger O. Phospho-choline as a pattern recognition ligand for CD36. J Lipid Res. 2005;46:969-976.
73. Catala A. Lipid peroxidation modifies the picture of membranes from the "fluid mosaic model" to the "lipid whisker model." Biochimie. 2012;94:101-109.
74. Bochkov VN, Mechtcheriakova D, Lucerna M, Huber J, Malli R, Graier WF, Hofer E, Binder BR, Leitinger N. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of erk/egr-1 and ca(++)/NFAT. Blood. 2002;99:199-206.